Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
73
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Clinicopathological and prognostic significance of pretreatment thrombocytosis in patients with endometrial cancer: a meta-analysis

Yi-Yang Bai1 Department of Medical Oncology, The First Affiliated Hospital, College of Medicine of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China
,
Lan Du2 Department of Obstetrics and Gynecology, Xi’an Angel Women’s and Children’s Hospital, Xian, Shaanxi, People’s Republic of China
,
Li Jing1 Department of Medical Oncology, The First Affiliated Hospital, College of Medicine of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China
,
Tao Tian1 Department of Medical Oncology, The First Affiliated Hospital, College of Medicine of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China
,
Xuan Liang1 Department of Medical Oncology, The First Affiliated Hospital, College of Medicine of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China
,
Min Jiao1 Department of Medical Oncology, The First Affiliated Hospital, College of Medicine of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China
,
Ke-Jun Nan1 Department of Medical Oncology, The First Affiliated Hospital, College of Medicine of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China
,
Hui Guo1 Department of Medical Oncology, The First Affiliated Hospital, College of Medicine of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of ChinaCorrespondence[email protected] [email protected]
&
Zhi-Ping Ruan1 Department of Medical Oncology, The First Affiliated Hospital, College of Medicine of Xi’an Jiaotong University, Xi’an, Shaanxi, People’s Republic of China
 show all
Pages 4283-4295 | Published online: 08 May 2019

References

  • Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387(10023):1094–1108. doi:10.1016/S0140-6736(15)00130-026354523
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
  • Pectasides D, Pectasides E, Economopoulos T. Systemic therapy in metastatic or recurrent endometrial cancer. Cancer Treat Rev. 2007;33(2):177–190. doi:10.1016/j.ctrv.2006.10.00717196749
  • Gupta D. Clinical behavior and treatment of endometrial cancer. Adv Exp Med Biol. 2017;943:47–74. doi:10.1007/978-3-319-43139-0_227910064
  • Murali R, Soslow RA, Weigelt B, et al. Classification of endometrial carcinoma: more than two types. Lancet Oncol. 2014;15(7):e268–78. doi:10.1016/S1470-2045(13)70591-624872110
  • Todenhöfer T, Renninger M, Schwentner C, Stenzl A, Gakis G. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors. BJU Int. 2012;110(11Pt B):E533–40. doi:10.1111/bju.2012.110.issue-11b22578156
  • Cohen JG, Tran AQ, Rimel BJ, et al. Thrombocytosis at secondary cytoreduction for recurrent ovarian cancer predicts suboptimal resection and poor survival. Gynecol Oncol. 2014;132(3):556–559. doi:10.1016/j.ygyno.2014.01.00324423879
  • Koulis TA, Kornaga EN, Banerjee R, et al. Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: A retrospective cohort study. Clin Transl Radiat Oncol. 2017;4:51–56. doi:10.1016/j.ctro.2017.05.00129594208
  • Takahashi R, Mabuchi S, Kuroda H, et al. The significance of pretreatment thrombocytosis and its association with neutrophilia in patients with surgically treated endometrial cancer. Int J Gynecol Cancer. 2017;27(7):1399–1407. doi:10.1097/IGC.00000000000101928604454
  • Heng S, Benjapibal M. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer. Asian Pac J Cancer Prev. 2014;15(23):10231–10236.25556452
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e100100. doi:10.1371/journal.pmed.10010019621070
  • Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z20652370
  • Abu-Zaid A, Alsabban M, Abuzaid M, AlOmar O, Salem H, Al-Badawi IA. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma. Ann Saudi Med. 2017;37(5):393–400. doi:10.5144/0256-4947.2017.39328988254
  • Andersen CL, Eskelund CW, Siersma VD, et al. Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer? Gynecol Oncol. 2015;139(2):312–318. doi:10.1016/j.ygyno.2015.09.01726407478
  • Gücer F, Moser F, Tamussino K, et al. Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol. 1998;70(2):210–214. doi:10.1006/gyno.1998.50789740692
  • Gorelick C, Andikyan V, Mack M, Lee YC, Abulafia O. Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer. 2009;19(8):1384–1389. doi:10.1111/IGC.0b013e3181a47d4720009894
  • Kizer NT, Hatem H, Nugent EK, et al. Chemotherapy response rates among patients with endometrial cancer who have elevated serum platelets. Int J Gynecol Cancer. 2015;25(6):1015–1022. doi:10.1097/IGC.000000000000045326098089
  • Njølstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol. 2013;131(2):410–415. doi:10.1016/j.ygyno.2013.08.03224004646
  • Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol. 2007;104(1):91–94. doi:10.1016/j.ygyno.2006.07.02016934317
  • Moeini A, Machida H, Takiuchi T, et al. Association of nonalcoholic fatty liver disease and venous thromboembolism in women with endometrial cancer. Clin Appl Thromb Hemost. 2016;23(8):1018–1027. doi:10.1177/107602961666592527582024
  • Wang YH, Deng SJ, Yang YD, et al. The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Biomark Med. 2017;11(2):195–210. doi:10.2217/bmm-2016-021428097884
  • Wang YH, Kang JK, Zhi YF, et al. The pretreatment thrombocytosis as one of prognostic factors for gastric cancer: A systematic review and meta-analysis. Int J Surg. 2018;53:304–311. doi:10.1016/j.ijsu.2018.03.08429654963
  • Cummings M, Merone L, Keeble C, et al. Preoperative neutrophil: lymphocyteand platelet: lymphocyteratios predict endometrial cancer survival. Br J Cancer. 2015;113(2):311–320. doi:10.1038/bjc.2015.20026079303
  • Oge T, Yalcin OT, Ozalp SS, Isikci T. Platelet volume as a parameter for platelet activation in patients with endometrial cancer. J Obstetrics Gynaecol. 2013;33(3):301–304. doi:10.3109/01443615.2012.758089
  • Wojtukiewicz MZ, Sierko E, Hempel D, Tucker SC, Honn KV. Platelets and cancer angiogenesis nexus. Cancer Metastasis Rev. 2017;36(2):249–262. doi:10.1007/s10555-017-9673-128681240
  • Li N. Platelets in cancer metastasis: to help the “villain” to do evil. Int J Cancer. 2016;138(9):2078–2087. doi:10.1002/ijc.2984726356352
  • Orellana R, Kato S, Erices R, et al. Platelets enhance tissue factor protein and metastasis initiating cell markers, and act as chemoattractants increasing the migration of ovarian cancer cells. BMC Cancer. 2015;15:290. doi:10.1186/s12885-015-1584-325886038
  • Menter DG, Tucker SC, Kopetz S, Sood AK, Crissman JD, Honn KV. Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev. 2014;33(1):231–269. doi:10.1007/s10555-014-9498-024696047
  • Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366(7):610–618. doi:10.1056/NEJMoa111035222335738
  • Guillem-Llobat P, Dovizio M, Bruno A, et al. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells. Oncotarget. 2016;7(22):32462–32477. doi:10.18632/oncotarget.865527074574
  • Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Ottawa Hospital Research Institute Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed July 10, 2018.

References

  • Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in metaanalyses. Ottawa Hospital Research Institute. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 710, 2018.
  • Abu-Zaid A, Alsabban M, Abuzaid M, AlOmar O, Salem H, Al-Badawi IA. Preoperative thrombocytosis as a prognostic factor in endometrioid-type endometrial carcinoma. Ann Saudi Med. 2017;37 (5):393–400. doi:10.5144/0256-4947.2017.39328988254
  • Andersen CL, Eskelund CW, Siersma VD, et al. Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer? Gynecol Oncol. 2015;139(2):312–318. doi:10.1016/j.ygyno.2015.09.017.
  • Gücer F, Moser F, Tamussino K, et al. Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol. 345 1998;70(2):210–214. doi:10.1006/gyno.1998.5078
  • Gorelick C, Andikyan V, Mack M, Lee YC, Abulafia O. Prognostic significance of preoperative thrombocytosis in patients with endometrial carcinoma in an inner-city population. Int J Gynecol Cancer. 2009;19(8):1384–1389. doi:10.1111/IGC.0b013e3181a47d4720009894
  • Heng S, Benjapibal M. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer. Asian Pac J Cancer Prev. 2014;15(23):10231–1023625556452
  • Kizer NT, Hatem H, Nugent EK, et al. Chemotherapy response rates among patients with endometrial cancer who have elevated serum platelets. Int J Gynecol Cancer. 2015;25(6):1015–1022. doi:10.1097/IGC.000000000000045326098089
  • Lerner DL, Walsh CS, Cass I, Karlan BY, Li AJ. The prognostic significance of thrombocytosis in uterine papillary serous carcinomas. Gynecol Oncol. 2007;104(1):91–94. doi:10.1016/j.ygyno.2006.07.02016934317
  • Moeini A, Machida H, Takiuchi T, et al. Association of nonalcoholic fatty liver disease and venous thromboembolism in women with endometrial cancer. Clin Appl Thromb Hemost. 2016;23(8):1018–1027. doi:10.1177/107602961666592510.27582024
  • Njølstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J. 355 Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol. 2013;131 (2):410–415. doi:10.1016/j.ygyno.2013.08.03224004646
  • Takahashi R, Mabuchi S, Kuroda H, et al. The significance of pretreatment thrombocytosis and its association with neutrophilia in patients with surgically treated endometrial cancer. Int J Gynecol Cancer. 2017;27(7):1399–1407. doi:10.1097/IGC.00000000000101928604454

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.